BIA makes appointments
This article was originally published in Scrip
Executive Summary
TheBIA, the UK's Bioindustry Association, has confirmed Dr Clive Dix as chairman of the board of directors. Dr Dix serves as non-executive chairman of Modern Biosciences and has more than 15 years experience serving in senior positions within the pharmaceutical industry. The association also elected Allan Marchington, a partner at Apposite Capital, a new member of its board of directors and reappointed Glyn Edwards, CEO ofAntisoma.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.